amlexanox has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, Y; Kuriki, H; Maki, Y; Makino, H; Saijo, T | 1 |
| Cho, CC; Chou, RH; Yu, C | 1 |
2 other study(ies) available for amlexanox and epidermal growth factor
| Article | Year |
|---|---|
Inhibition by amoxanox (AA-673) of the immunologically, leukotriene D4- or platelet-activating factor-stimulated bronchoconstriction in guinea pigs and rats.
Topics: Aminopyridines; Animals; Asthma; Bronchi; Cromolyn Sodium; Epidermal Growth Factor; Female; Guinea Pigs; Histamine Release; Immunoglobulin E; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; SRS-A | 1985 |
Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation.
Topics: Aminopyridines; Anti-Allergic Agents; Anti-Inflammatory Agents; Calcium; Cell Differentiation; Cell Proliferation; Cell Survival; Epidermal Growth Factor; Fluorescence; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Mutation; Protein Binding; Protein Conformation; S100 Calcium-Binding Protein A4; Signal Transduction; Trypsin | 2016 |